The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
In early March, Congress adopted legislation that updated the Medicare Physician Fee Schedule (MPFS) conversion factor for…
On Saturday, March 9, the Centers for Medicare & Medicaid Services (CMS) released a statement…
President Biden’s State of the Union Address State of the Union Transcript State of the Union Video…
12/01/24: Research Grant Cycle
Learn more
04/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to give you educational programming that encompasses your full scope of practice. Join us for the new Explorers Course 2025: Surgical & Medical Management of Airway Disease in Otolaryngology. Learn More
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More and Register
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access Feb 27 – May 27, 2025
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Book Your Room
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
Sitting here at the Basic Course I cannot help by be inspired. Such a great…
Does it seem like everything old is new again? The 70s seem to be back…
Can you believe we just celebrated Memorial Day and are heading into summer? I am…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
Those interested can still register and stream a video of the webcast at the link below: https://www.workcast.com/register?cpak=2535926321003375 The 2021 update of ICAR: Rhinosinusitis has been recently published in the International Forum of Allergy and Rhinology and many are asking “What…
AAOA's "Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin. The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases. Biologic…
Have novel research tied to allergy, inflammatory disease in ENT, comprehensive management of allergy and inflammatory disease, or another aspect impacting ENT patient care? AAOA is currently soliciting research abstracts for consideration for its Virtual 2021 Annual Meeting. All 2021…
By Beth Wang / April 15, 2021 at 11:57 AM The House on Wednesday (April 14) passed a bipartisan bill that will require food makers declare sesame as an allergen on their food labels. The bill, which cleared the Senate in March,…
A team led by AAOA Education Coordinator Cecelia Damask, DO, FAAOA, and AAOA President (2018-2019) Matthew Ryan, MD, FAAOA recently published a new supplement to the AAO-HNS OTO Journal on Targeted Molecular Therapies in Allergy and Rhinology. Read More
A brief summary of the CMS Coding 2021 – AAOA Zoomcast Series: Just In Time Content for AAOA Members, Part II. Written by Christie DeMason MD, FAAOA. Panelists: James Connolly, MD; Ayesha Khalid, MD, MBA; Nalin Patel, MD; Robert Stachler,…
A brief summary of the Re-Engaging Patients 2021 - AAOA Zoomcast Series: Just In Time Content for AAOA Members, Part II. Written by Jodi Zuckerman MD, FAAOA. Panelists: Steven Houser, MD; Haidy Marzouk, MD; Paul Neubauer, MD; Nalin Patel, MD;…
A brief summary of the COVID-19 Vaccines - AAOA Zoomcast Series: Just In Time Content for AAOA Members, Part II. Written by Haidy Marzouk, MD, FAAOA. *Information related to COVID 19 is rapidly evolving Panelists: Michelle Liu, MD; Nalin Patel,…
In the third episode of the AAOA’s NEW podcast series Today in ENT Allergy: AAOA’s Podcast, Jennifer Villwock, MD, FAAOA speaks with Gavin Setzen, MD, FAAOA. They are discussing the integral role allergy plays in ENT practice. How and why…
Joint Statement by the American Academy of Otolaryngology–Head and Neck Surgery (AAO–HNS) and the American Academy of Otolaryngic Allergy (AAOA) Allergic reactions are uncommon and anaphylaxis following vaccines is rare, occurring at a rate of approximately one per million doses…
